Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

49.08
-1.1500-2.29%
Post-market: 48.90-0.1800-0.37%19:32 EDT
Volume:1.49M
Turnover:73.66M
Market Cap:9.38B
PE:-11.99
High:50.73
Open:50.61
Low:48.84
Close:50.23
52wk High:51.86
52wk Low:21.72
Shares:191.17M
Float Shares:151.20M
Volume Ratio:0.69
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0935
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-41.96%
PB:-5.25
PE(LYR):-17.05

Loading ...

May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report